🇺🇸 FDA
Company

Lakewood-Amedex

Lakewood-Amedex Biotherapeutics

LABT pharma USA

Quick answer

Lakewood-Amedex is a pharma company (LABT) headquartered in UNIVERSITY PARK, FL, USA with 4 tracked pipeline programs.

Pipeline (4)

project

5% Bisphosphocin Topical Gel

Chronic Diabetic Foot Ulcers

Phase 2 · small_molecule · terminated

1 trials project

5% Nu-3 gel

Diabetic Foot Infection

Phase 2 · small_molecule · active

1 trials project

Antimicrobial agent

Diabetic Foot Ulcers (DFUs)

Phase 2 · small_molecule · active

1 trials project

Bisphosphocin Nu-3

Diabetic Foot Infections

Phase 2 · small_molecule · completed

1 trials

Patents (8)

patent

US 12156883

Bisphosphocin gel formulations and uses thereof

Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12054509

Antimicrobial compounds, compositions, and uses thereof

Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12030908

Antimicrobial compounds, compositions, and uses thereof

Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11795192

Antimicrobial compounds, compositions, and uses thereof

Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11377468

Antimicrobial compounds, compositions, and uses thereof

Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11123357

Methods and compositions for treating oral mucositis

Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11096954

Bisphosphocin gel formulations and uses thereof

Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10981943

Antimicrobial compounds, compositions, and uses thereof

Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)